+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
VEERHEALTH VEERHEALTH

Veerhealth Care Share Price

₹48.40 -0.59 (-1.2%)
189.82% Gain from 52W Low

30 Oct, 2026 4:01 PM (IST)

Veerhealth Care live price: ₹48.40. It opened at ₹50 vs previous close ₹49; intraday high/low: ₹50/₹48. The 50 & 200 DMA stand at ₹48.00/₹36.00.

Veerhealth Care Performance

  • Today's Low
  • ₹48
  • Today's High
  • ₹50
  • 52 Week Low
  • ₹17
  • 52 Week High
  • ₹52
  • Open Price₹50
  • Previous Close₹49
  • Volume165,871
  • 50 DMA₹48.00
  • 100 DMA₹43.30
  • 200 DMA₹36.00

Veerhealth Care Chart

Investment Returns

  • Over 1 Month -2%
  • Over 3 Month + 15.07%
  • Over 6 Month + 134.84%
  • Over 1 Year + 170.24%

Smart Investing Starts Here Start SIP with Veerhealth Care for Steady Growth!

Invest Now

Veerhealth Care Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 63.3
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 97
  • P/B Ratio
  • 4
  • Average True Range
  • 1.6
  • EPS
  • 0.8
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.1
  • RSI
  • 38.81
  • MFI
  • 27.94

Latest Stock News Updates

Veerhealth Care Ltd - 511523 - Board Meeting Intimation for Approval Of Unaudited Financial Results For Quarter And Half Year Ended September, 2026

Veerhealth Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve 1. To consider and approve unaudited financial results of the Company for the quarter and half year ended 30th September, 2026.

Veerhealth Care Ltd - 511523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Submission of the transcript of Investors'' call held on 24th October, 2026

Veerhealth Care Ltd - 511523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Outcome of the investors'' meeting under Reg 30 of LODR held on 24.10.2026

Veerhealth Care Financials

Veerhealth Care Technicals

EMA & SMA

Current Price
₹48.40
-0.59 (-1.2%)
pointer
  • Bearish Moving Average 10
  • Bullish Moving Average 6
  • 20 Day
  • ₹49.30
  • 50 Day
  • ₹48.00
  • 100 Day
  • ₹43.30
  • 200 Day
  • ₹36.00

Resistance and Support

48.63 Pivot Speed
  • R3 50.70
  • R2 50.10
  • R1 49.20
  • S1 47.80
  • S2 47.10
  • S3 46.30

Veerhealth Care Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-13 Quarterly Results
2026-05-30 Audited Results & Dividend
2026-03-28 Preferential Issue of shares Inter alia, to consider 1. Proposal for raising of funds by way of issue of one or more instruments including equity shares/convertible securities either by way of Preferential Issue or any other mode
2026-02-14 Quarterly Results
2025-11-12 Quarterly Results
Date Purpose Remarks
2016-11-30 Split Consolidation of equity shares from Re. 1/- to Rs. 10/-.
2005-10-05 Split Stock split from Rs. 10/- to Rs. 1/-
Date Purpose Remarks
2023-09-22 Bonus Bonus issue in the ratio of 1:1 of Rs. 10/-.

Veerhealth Care Shareholding Pattern

68.12%
31.88%
0%

About Veerhealth Care

Veerhealth Care is engaged in the business of trading and manufacturing and marketing research based ayurvedic medicines. View More
  • NSE Symbol
  • VEERHEALTH
  • BSE Symbol
  • 511523
  • ISIN
  • INE882C01035

Similar Stocks to Veerhealth Care

Veerhealth Care FAQs

Veerhealth Care share price is ₹48 As on 31 October, 2026 | 08:39

The Market Cap of Veerhealth Care is ₹96.8 Cr As on 31 October, 2026 | 08:39

The P/E ratio of Veerhealth Care is 63.3 As on 31 October, 2026 | 08:39

The PB ratio of Veerhealth Care is 4 As on 31 October, 2026 | 08:39

The 52 week High & Low of Veerhealth Care is ₹52/₹16.7 respectively As on 31 October, 2026 | 08:39

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23